跳至主要内容
临床试验/NCT02082548
NCT02082548已完成不适用

An International Multicenter Clustered Randomized Controlled Trial to imProve Treatment With AntiCoagulanTs in Patients With Atrial Fibrillation.

Duke University5 个研究点 分布在 5 个国家目标入组 2,374 人开始时间: 2014年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
2,374
试验地点
5
主要终点
Change in proportion of patients taking oral anticoagulants

研究概览

简要总结

To determine whether a comprehensive evaluation and customized multilevel educational interventions will increase the rate of use of oral anticoagulants and the adherence and persistence of use in patients with atrial fibrillation. Our hypothesis is that there will be differences in the use of oral anticoagulants and the persistence in patients between the control and interventional group. There will be a greater change in the use of oral anticoagulants over one year in the cohort in the intervention sites than the control sites. This will be due to two factors: greater initiation of oral anticoagulants among patients not treated at baseline and greater persistence of treatment for those on treatment at baseline

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over the age of 18 with paroxysmal, persistent or permanent atrial fibrillation who have a 12-lead ECG showing atrial fibrillation and/or more than one rhythm strip showing atrial fibrillation at least 2 weeks apart, not due to a reversible cause (like post-CABG))
  • At least one of the traditional CHADS2 risk factors or at least two CHA2DS2 VASc risk factors

排除标准

  • Mechanical prosthetic valve
  • Clinically unstable at the time of enrollment (ie, with ongoing shock)
  • Terminal illness and/or comfort care
  • Unable to provide consent (e.g. severe cognitive impairment)
  • Patients unable to have one year of follow-up for any reason
  • Clear and absolute contraindication to oral anticoagulation (for example, active bleeding or recent life-threatening bleeding such as ICH)

研究组 & 干预措施

Intervention

Experimental

educational intervention arm

干预措施: Educational Intervention (Other)

control

No Intervention

Standard of care

结局指标

主要结局

Change in proportion of patients taking oral anticoagulants

时间窗: 1 year

Change in proportion of patients taking oral anticoagulants from baseline to one year

次要结局

  • Death, total(1 year)
  • Major and non-major clinically relevant bleeding(1 year)
  • Change in proportion of patients who are not on anticoagulation at baseline and are on anticoagulation(1 year)
  • Stroke, hemorrhagic and non-hemorrhagic(1 year)
  • Change in proportion of patients able to continue anticoagulation(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验